Prostate-specific antigen doubling time and response to cabazitaxel in a hormone-resistant metastatic prostate cancer patient

by Ghosn, Marwan, Dagher, Alain, El-Karak, Fadi
Published 2015

Multidisciplinary management of clear-cell renal cell carcinoma in Africa and the Middle East: current practice and recommendations for improvement

by Zekri, Jamal, Dreosti, Lydia M, Ghosn, Marwan, Hamada, Emad, Jaloudi, Mohamed, Khorshid, Ola, Larbaoui, Blaha
Published 2015

Dilemma of first line regimens in metastatic pancreatic adenocarcinoma

by Ghosn, Marwan, Ibrahim, Tony, Assi, Tarek, El Rassy, Elie, Kourie, Hampig Raphael, Kattan, Joseph
Published 2016

Sequential Therapy with Gemcitabine and Carboplatin Followed by Paclitaxel as First Line Treatment for Advanced Urothelial Cancer

by Kattan, Joseph G, Boutros, Celine Y, Farhat, Fadi S, Chahine, Georges Y, Musallam, Khaled M, Ghosn, Marwan G
Published 2012

Phase I and II Study of Gemcitabine and Vinorelbine in Heavily Pretreated Patients with Metastatic Breast Cancer and Review of the Literature

by Abdayem, Pamela, Ghosn, Marwan, Valero, Vicente, Walters, Ronald, Arun, Banu, Murray, James L., Theriault, Richard, Frye, Debbie, Ibrahim, Nuhad K.
Published 2014

Where does chemotherapy stands in the treatment of ampullary carcinoma? A review of literature

by Ghosn, Marwan, Kourie, Hampig Raphael, El Rassy, Elie, Haddad, Fady Ghassan, Hanna, Colette, El Karak, Fadi, Nasr, Dolly
Published 2016

Phospho-MEK1/2 and uPAR Expression Determine Sensitivity of AML Blasts to a Urokinase-Activated Anthrax Lethal Toxin (PrAgU2/LF)1

by Bekdash, Amira, Darwish, Manal, Timsah, Zahra, Kassab, Elias, Ghanem, Hadi, Najjar, Vicky, Ghosn, Marwan, Nasser, Selim, El-Hajj, Hiba, Bazerbachi, Ali, Liu, Shihui, Leppla, Stephen H., Frankel, Arthur E., Abi-Habib, Ralph J.
Published 2015